These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 21968301)
1. [Significance of the expression of lymphocytes and cytokines infiltrating in HCC]. Ye YB; Peng F; Li JY; Lin LP; Zheng XW; Zhou D; Li C; Li QL; Cai XW Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1056-60. PubMed ID: 21968301 [TBL] [Abstract][Full Text] [Related]
2. Correlation between expression of cyclooxygenase-2 and the presence of CD4+ infiltrating T-lymphocyte in human primary hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Zhou LD; Li XY; Li LX; Luo QZ; Tian W; Fu CY; Zhou JH Hepatogastroenterology; 2008; 55(82-83):345-50. PubMed ID: 18613363 [TBL] [Abstract][Full Text] [Related]
3. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic analysis of tumor-infiltrating lymphocytes in hepatocellular carcinoma. Chen CH; Lee HS; Huang GT; Yang PM; Yu WY; Cheng KC; Lee PH; Jeng YM; Chen DS; Sheu JC Hepatogastroenterology; 2007; 54(77):1529-33. PubMed ID: 17708291 [TBL] [Abstract][Full Text] [Related]
5. Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients. Fu J; Xu D; Liu Z; Shi M; Zhao P; Fu B; Zhang Z; Yang H; Zhang H; Zhou C; Yao J; Jin L; Wang H; Yang Y; Fu YX; Wang FS Gastroenterology; 2007 Jun; 132(7):2328-39. PubMed ID: 17570208 [TBL] [Abstract][Full Text] [Related]
6. Increased CD4(+) CD69(+) CD25(-) T cells in patients with hepatocellular carcinoma are associated with tumor progression. Zhu J; Feng A; Sun J; Jiang Z; Zhang G; Wang K; Hu S; Qu X J Gastroenterol Hepatol; 2011 Oct; 26(10):1519-26. PubMed ID: 21557772 [TBL] [Abstract][Full Text] [Related]
7. Increased mRNA expression of chemokines in hepatocellular carcinoma with tumor-infiltrating lymphocytes. Hirano S; Iwashita Y; Sasaki A; Kai S; Ohta M; Kitano S J Gastroenterol Hepatol; 2007 May; 22(5):690-6. PubMed ID: 17444857 [TBL] [Abstract][Full Text] [Related]
8. Increased liver-infiltrating CD8+FoxP3+ regulatory T cells are associated with tumor stage in hepatocellular carcinoma patients. Yang ZQ; Yang ZY; Zhang LD; Ping-Bie ; Wang SG; Ma KS; Li XW; Dong JH Hum Immunol; 2010 Dec; 71(12):1180-6. PubMed ID: 20870003 [TBL] [Abstract][Full Text] [Related]
9. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Unitt E; Rushbrook SM; Marshall A; Davies S; Gibbs P; Morris LS; Coleman N; Alexander GJ Hepatology; 2005 Apr; 41(4):722-30. PubMed ID: 15791620 [TBL] [Abstract][Full Text] [Related]
10. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. Gao Q; Qiu SJ; Fan J; Zhou J; Wang XY; Xiao YS; Xu Y; Li YW; Tang ZY J Clin Oncol; 2007 Jun; 25(18):2586-93. PubMed ID: 17577038 [TBL] [Abstract][Full Text] [Related]
11. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by gamma-interferon in lymphocyte recruitment to hepatocellular carcinoma. Yoong KF; Afford SC; Jones R; Aujla P; Qin S; Price K; Hubscher SG; Adams DH Hepatology; 1999 Jul; 30(1):100-11. PubMed ID: 10385645 [TBL] [Abstract][Full Text] [Related]
12. Expression of inhibitory receptors in natural killer (CD3(-)CD56(+)) cells and CD3(+)CD56(+) cells in the peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with primary hepatocellular carcinoma. Yuen MF; Norris S Clin Immunol; 2001 Dec; 101(3):264-9. PubMed ID: 11726217 [TBL] [Abstract][Full Text] [Related]
14. Increase of CD4+ CD25+ regulatory T-cells in the liver of patients with hepatocellular carcinoma. Yang XH; Yamagiwa S; Ichida T; Matsuda Y; Sugahara S; Watanabe H; Sato Y; Abo T; Horwitz DA; Aoyagi Y J Hepatol; 2006 Aug; 45(2):254-62. PubMed ID: 16600416 [TBL] [Abstract][Full Text] [Related]
15. Associations between infiltrating lymphocyte subsets and hepatocellular carcinoma. Guo CL; Yang HC; Yang XH; Cheng W; Dong TX; Zhu WJ; Xu Z; Zhao L Asian Pac J Cancer Prev; 2012; 13(11):5909-13. PubMed ID: 23317279 [TBL] [Abstract][Full Text] [Related]
16. [The presence and the significance of CD4+CD25+ regulatory T cells in livers of patients with hepatocellular carcinoma]. Yang XH; Liu BR; Jiang HC Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):279-82. PubMed ID: 17456316 [TBL] [Abstract][Full Text] [Related]
17. Infiltrating memory/senescent T cell ratio predicts extrahepatic metastasis of hepatocellular carcinoma. Gao Q; Zhou J; Wang XY; Qiu SJ; Song K; Huang XW; Sun J; Shi YH; Li BZ; Xiao YS; Fan J Ann Surg Oncol; 2012 Feb; 19(2):455-66. PubMed ID: 21792513 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of tumor-infiltrating FOXP3+ regulatory T cells in patients with hepatocellular carcinoma. Sasaki A; Tanaka F; Mimori K; Inoue H; Kai S; Shibata K; Ohta M; Kitano S; Mori M Eur J Surg Oncol; 2008 Feb; 34(2):173-9. PubMed ID: 17928188 [TBL] [Abstract][Full Text] [Related]
19. FOXP3+ regulatory T cells affect the development and progression of hepatocarcinogenesis. Kobayashi N; Hiraoka N; Yamagami W; Ojima H; Kanai Y; Kosuge T; Nakajima A; Hirohashi S Clin Cancer Res; 2007 Feb; 13(3):902-11. PubMed ID: 17289884 [TBL] [Abstract][Full Text] [Related]
20. Increased expression of cyclooxygenase-2 and increased infiltration of regulatory T cells in tumors of patients with hepatocellular carcinoma. Gao YW; Chen YX; Wang ZM; Jin J; Li XY; Zhou le D; Huo Z; Zhou JH; Chen W Digestion; 2009; 79(3):169-76. PubMed ID: 19329856 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]